Memphis Pharmaceuticals & Chemical Industries reported earnings results for the nine months ended March 31, 2024. For the nine months, the company reported sales was EGP 664.58 million compared to EGP 440.47 million a year ago. Net income was EGP 166.37 million compared to EGP 35.06 million a year ago.